Our study showed that UA improved the intestinal bacteria by inhibiting the NOX4/NLRP3 inflammasome signaling pathway, thereby restoring liver function and slowing the occurrence and development of liver fibrosis. The gene discussed is NLRP3; the disease is Hepatic fibrosis.